SequelSEC

GE HealthCare Technologies Inc. GEHC

X-Ray Apparatus & Tubes & Related Irradiation Apparatus · CIK 0001932393 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$20.62B
Fiscal year ended 2025-12-31
Operating income
$2.76B
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$34.00BMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$74.60Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income16.3×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue1.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity3.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

Valuation over time

16.3× earnings today, against a median of 16.6× across 3 years on record. In line with its own history.

Float measuredPublic floatFloat / net income
2025-06-30$34.00B16.3×
2024-06-28$33.00B16.6×
2023-06-30$32.00B20.4×

Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.

GE HealthCare Technologies Inc. (GEHC) reported revenue of $20.62B and net income of $2.08B for the fiscal year ended 2025-12-31. This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from GE HealthCare Technologies Inc.’s SEC filings, each linked to the filing it came from.

Income

GE HealthCare Technologies Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue$20.62B$19.67B$19.55B$18.34B$17.58B
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profit$8.25B$8.20B$7.92B$7.18B$7.17B
Operating income$2.76B$2.62B$2.44B$2.52B$2.80B
Net income$2.08B$1.99B$1.57B$1.92B$2.25B
Research & development$1.26B$1.31B$1.20B$1.03B$816.00M
Weighted-average diluted sharesshares 458.00Mshares 459.00Mshares 458.00Mshares 454.00Mshares 454.00M
Pretax income$2.77B$2.58B$2.36B$2.51B$2.88B
Income tax expense$614.00M$531.00M$743.00M$563.00M$600.00M
Diluted EPS$4.55$4.34$3.03$4.22$4.95
Selling, general & administrative$4.22B$4.27B$4.28B$3.63B$3.56B
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

GE HealthCare Technologies Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-31
Cash & equivalents$4.49B$2.87B$2.49B$1.44BUnavailable
Total assets$36.91B$33.09B$32.45B$27.54BUnavailable
Current assets$12.50B$9.90B$9.41B$8.32BUnavailable
Total liabilities$26.31B$24.44B$25.14B$17.95BUnavailable
Current liabilities$9.10B$9.55B$8.98B$7.19BUnavailable
Total equity incl. NCI$10.39B$8.46B$7.14B$9.36B$16.68B
Temporary (mezzanine) equity$209.00M$188.00M$165.00M$230.00M$220.00M
Inventory$2.23B$1.94B$1.96B$2.16BUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailable
Goodwill$13.49B$13.14B$12.94B$12.81B$12.89B
Long-term debt$9.50B$7.45B$8.44B$8.23BUnavailable
Accounts payable$3.25B$3.04B$2.95B$2.94BUnavailable

Cash flow

GE HealthCare Technologies Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-31
Operating cash flowUnavailableUnavailableUnavailableUnavailableUnavailable
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$1.05B-$914.00M-$558.00M-$398.00M-$1.76B
Financing cash flow$617.00M-$573.00M-$478.00M-$822.00M-$263.00M
Net change in cash$1.62B$387.00M$1.06B$890.00M-$451.00M
Stock-based compensation$130.00M$125.00M$114.00M$67.00M$76.00M
Common dividends paid$64.00M$55.00M$41.00M$0$0
Common share repurchases$200.00M$0$0UnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

GE HealthCare Technologies Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin40.0%41.7%40.5%39.1%40.8%
Operating margin13.4%13.3%12.5%13.8%15.9%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue0.6%0.6%0.6%0.4%0.4%
Current ratio1.37x1.04x1.05x1.16xUnavailable
Revenue YoY growth4.8%0.6%6.6%4.3%Unavailable
Net margin10.1%10.1%8.0%10.4%12.8%
R&D / revenue6.1%6.7%6.2%5.6%4.6%
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.91xUnavailableUnavailableUnavailableUnavailable
Effective tax rate22.2%20.6%31.5%22.4%20.9%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GEHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-28View SEC filing
10-Q · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing

Companies in the same industry

BFLY

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.